Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital (Beijing Cancer Hospital), Beijing.
Am J Surg Pathol. 2018 Feb;42(2):160-171. doi: 10.1097/PAS.0000000000000951.
SATB2 is a sensitive marker for colorectal adenocarcinomas. No study has investigated its diagnostic utility in metastatic Krukenberg tumors (MKTs) of the ovary. Here we performed immunohistochemical staining SATB2 in 70 MKTs of various origins (stomach 27, colorectum 13, appendix 20 including 19 metastatic adenocarcinomas ex goblet cell carcinoids [AdexGCC] and 1 conventional poorly differentiated carcinoma with signet ring cells, breast 5, bladder 3, lung 2) to assess its diagnostic utility. We also compared SATB2 with CDX2, CK7, CK20, chromogranin, and synaptophysin in MKTs of gastric origin (MKTs-stomach), those of colorectal origin (MKTs-colorectum) and those due to appendiceal AdexGCCs (MKT-AdexGCCs) for their sensitivity and specificity to distinguish these tumors. SATB2 staining was seen in 1/27 (4%) MKTs-stomach (40% cells), 7/13 (54%) MKTs-colorectum (mean: 17% cells, median: 7%, range: 2% to 60%), and 19/19 (100%) of MKT-AdexGCCs (mean: 97% cells, median: 100%, range: 80% to 100%) (P<0.01 between any two). SATB2 staining was seen in 1/1 metastatic appendiceal poorly differentiated carcinoma with signet ring cells (5% cells), 1/3 MKTs of bladder origin (60% cells), 0/2 MKTs of pulmonary origin, and 1/5 MKTs of breast origin (10% cells). SATB2 staining was diffuse strong in MKT-AdexGCCs whereas in other MKTs it was focal and weak in the signet ring and nonsignet ring nonglandular cells and from focal weak to diffuse strong in well-formed glands. MKTs-stomach, MKTs-colorectum, and MKT-AdexGCCs showed no significant staining difference in CDX2 (100%, 100%, 100% cases, respectively; P=1.0), CK20 (96%, 100%, 100%, respectively; P=1.0), chromogranin (59%, 31%, 63%, respectively; P>0.05) or synaptophysin (59%, 63%, 84%, respectively; P>0.05) but they had significant difference in CK7 staining (93%, 8%, 42%, respectively; P<0.05). Among these 6 markers, SATB2 is the best one to distinguish MKT-AdexGCCs from MKTs-stomach (100% sensitivity, 96% specificity) and MKTs-colorectum (100% sensitivity and 100% specificity if staining more than 75% tumor cells as the cutoff). In distinguishing MKTs-stomach from MKTs-colorectum, SATB2 is not as good as CK7 which is the best marker. Our results indicate that SATB2 is a highly sensitive marker (100% sensitivity) for metastatic MKT-AdexGCCs with high specificity (100% specificity when showing strong staining in at least 75% cells) among MKTs. SATB2 is a useful marker for determining the primary sites of MKTs of the ovary.
SATB2 是结直肠癌的敏感标志物。尚无研究调查其在转移性 Krukenberg 卵巢肿瘤(MKT)中的诊断效用。在此,我们对 70 例不同来源的 MKT(胃 27 例、结直肠 13 例、阑尾 20 例,包括 19 例转移性肠嗜铬细胞瘤来源的腺癌细胞癌[AdexGCC]和 1 例传统低分化伴有印戒细胞的癌,乳腺 5 例、膀胱 3 例、肺 2 例)进行了 SATB2 免疫组织化学染色,以评估其诊断效用。我们还比较了 SATB2 与 CDX2、CK7、CK20、嗜铬粒蛋白和突触素在胃来源的 MKT(MKT-胃)、结直肠来源的 MKT(MKT-结直肠)和阑尾 AdexGCC 来源的 MKT(MKT-AdexGCC)中的敏感性和特异性,以区分这些肿瘤。SATB2 染色在 27 例 MKT-胃中的 1 例(4%)(40%的细胞)、13 例 MKT-结直肠中的 7 例(54%)(平均:17%的细胞,中位数:7%,范围:2%至 60%)和 19 例 MKT-AdexGCC 中的 19 例(100%)(平均:97%的细胞,中位数:100%,范围:80%至 100%)(任意两组之间 P<0.01)。SATB2 染色见于 1 例转移性阑尾低分化伴有印戒细胞的癌(5%的细胞)、3 例膀胱来源的 MKT 中的 1 例(60%的细胞)、2 例肺来源的 MKT 中的 0 例和 5 例乳腺来源的 MKT 中的 1 例(10%的细胞)。MKT-AdexGCC 中 SATB2 染色弥漫强阳性,而在其他 MKT 中,在印戒细胞和非印戒细胞非腺体细胞中呈局灶性和弱阳性,在形态良好的腺体中从局灶性弱阳性到弥漫强阳性。MKT-胃、MKT-结直肠和 MKT-AdexGCC 在 CDX2(分别为 100%、100%和 100%病例;P=1.0)、CK20(分别为 96%、100%和 100%病例;P=1.0)、嗜铬粒蛋白(分别为 59%、31%和 63%病例;P>0.05)或突触素(分别为 59%、63%和 84%病例;P>0.05)染色方面无显著差异,但 CK7 染色存在显著差异(分别为 93%、8%和 42%病例;P<0.05)。在这 6 种标志物中,SATB2 是区分 MKT-AdexGCC 与 MKT-胃(100%的敏感性,96%的特异性)和 MKT-结直肠(如果将 75%以上的肿瘤细胞作为截定点,100%的敏感性和 100%的特异性)的最佳标志物。在区分 MKT-胃与 MKT-结直肠时,SATB2 不如 CK7 好,CK7 是最佳标志物。我们的结果表明,SATB2 是一种高度敏感的标志物(100%的敏感性),对于转移性 MKT-AdexGCC 具有高特异性(如果在至少 75%的细胞中显示强染色,特异性为 100%)。SATB2 是确定卵巢 MKT 原发部位的有用标志物。